204 related articles for article (PubMed ID: 19447886)
21. Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseases.
Korkmaz B; Jenne DE; Gauthier F
Int Immunopharmacol; 2013 Dec; 17(4):1198-205. PubMed ID: 23886601
[TBL] [Abstract][Full Text] [Related]
22. Membrane proteinase 3 (mPR3) expression on neutrophils is not increased in localized Wegener's granulomatosis (WG) and Churg-Strauss syndrome (CSS).
Holle JU; Wu QJ; Moosig F; Gross WL; Csernok E
Clin Exp Rheumatol; 2010; 28(1 Suppl 57):46-50. PubMed ID: 20412702
[TBL] [Abstract][Full Text] [Related]
23. Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation.
Grimminger F; Hattar K; Papavassilis C; Temmesfeld B; Csernok E; Gross WL; Seeger W; Sibelius U
J Exp Med; 1996 Oct; 184(4):1567-72. PubMed ID: 8879231
[TBL] [Abstract][Full Text] [Related]
24. The presence of membrane Proteinase 3 in neutrophil lipid rafts and its colocalization with FcgammaRIIIb and cytochrome b558.
David A; Fridlich R; Aviram I
Exp Cell Res; 2005 Aug; 308(1):156-65. PubMed ID: 15916759
[TBL] [Abstract][Full Text] [Related]
25. Pathogenicity of Proteinase 3-Anti-Neutrophil Cytoplasmic Antibody in Granulomatosis With Polyangiitis: Implications as Biomarker and Future Therapies.
Granel J; Korkmaz B; Nouar D; Weiss SAI; Jenne DE; Lemoine R; Hoarau C
Front Immunol; 2021; 12():571933. PubMed ID: 33679731
[TBL] [Abstract][Full Text] [Related]
26. 4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis.
Granel J; Lemoine R; Morello E; Gallais Y; Mariot J; Drapeau M; Musnier A; Poupon A; Pugnière M; Seren S; Nouar D; Gouilleux-Gruart V; Watier H; Korkmaz B; Hoarau C
Front Immunol; 2020; 11():573040. PubMed ID: 33101296
[TBL] [Abstract][Full Text] [Related]
27. Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls.
van Rossum AP; Huitema MG; Stegeman CA; Bijl M; de Leeuw K; Van Leeuwen MA; Limburg PC; Kallenberg CG
Ann Rheum Dis; 2007 Oct; 66(10):1350-5. PubMed ID: 17446240
[TBL] [Abstract][Full Text] [Related]
28. New selective peptidyl di(chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases.
Guarino C; Legowska M; Epinette C; Kellenberger C; Dallet-Choisy S; Sieńczyk M; Gabant G; Cadene M; Zoidakis J; Vlahou A; Wysocka M; Marchand-Adam S; Jenne DE; Lesner A; Gauthier F; Korkmaz B
J Biol Chem; 2014 Nov; 289(46):31777-31791. PubMed ID: 25288799
[TBL] [Abstract][Full Text] [Related]
29. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.
Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B
Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715
[TBL] [Abstract][Full Text] [Related]
30. Inhibitors and Antibody Fragments as Potential Anti-Inflammatory Therapeutics Targeting Neutrophil Proteinase 3 in Human Disease.
Korkmaz B; Lesner A; Guarino C; Wysocka M; Kellenberger C; Watier H; Specks U; Gauthier F; Jenne DE
Pharmacol Rev; 2016 Jul; 68(3):603-30. PubMed ID: 27329045
[TBL] [Abstract][Full Text] [Related]
31. NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils.
von Vietinghoff S; Tunnemann G; Eulenberg C; Wellner M; Cristina Cardoso M; Luft FC; Kettritz R
Blood; 2007 May; 109(10):4487-93. PubMed ID: 17244676
[TBL] [Abstract][Full Text] [Related]
32. Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool.
Halbwachs-Mecarelli L; Bessou G; Lesavre P; Lopez S; Witko-Sarsat V
FEBS Lett; 1995 Oct; 374(1):29-33. PubMed ID: 7589506
[TBL] [Abstract][Full Text] [Related]
33. Different forms of alpha-1 antitrypsin and neutrophil activation mediated by human anti-PR3 IgG antibodies.
Surmiak M; Sanak M
Pharmacol Rep; 2016 Dec; 68(6):1276-1284. PubMed ID: 27689755
[TBL] [Abstract][Full Text] [Related]
34. Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the - 564 A/G promotor polymorphism.
Abdgawad M; Hellmark T; Gunnarsson L; Westman KW; Segelmark M
Clin Exp Immunol; 2006 Jul; 145(1):63-70. PubMed ID: 16792675
[TBL] [Abstract][Full Text] [Related]
35. Anti-proteinase 3 antibody activation of neutrophils can be inhibited by alpha1-antitrypsin.
Rooney CP; Taggart C; Coakley R; McElvaney NG; O'Neill SJ
Am J Respir Cell Mol Biol; 2001 Jun; 24(6):747-54. PubMed ID: 11415941
[TBL] [Abstract][Full Text] [Related]
36. A substrate-based approach to convert SerpinB1 into a specific inhibitor of proteinase 3, the Wegener's granulomatosis autoantigen.
Jégot G; Derache C; Castella S; Lahouassa H; Pitois E; Jourdan ML; Remold-O'Donnell E; Kellenberger C; Gauthier F; Korkmaz B
FASEB J; 2011 Sep; 25(9):3019-31. PubMed ID: 21670065
[TBL] [Abstract][Full Text] [Related]
37. A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis.
Witko-Sarsat V; Lesavre P; Lopez S; Bessou G; Hieblot C; Prum B; Noël LH; Guillevin L; Ravaud P; Sermet-Gaudelus I; Timsit J; Grünfeld JP; Halbwachs-Mecarelli L
J Am Soc Nephrol; 1999 Jun; 10(6):1224-33. PubMed ID: 10361860
[TBL] [Abstract][Full Text] [Related]
38. The use of small molecule high-throughput screening to identify inhibitors of the proteinase 3-NB1 interaction.
Choi M; Eulenberg C; Rolle S; von Kries JP; Luft FC; Kettritz R
Clin Exp Immunol; 2010 Aug; 161(2):389-96. PubMed ID: 20456416
[TBL] [Abstract][Full Text] [Related]
39. Complexes between proteinase 3, alpha 1-antitrypsin and proteinase 3 anti-neutrophil cytoplasm autoantibodies: a comparison between alpha 1-antitrypsin PiZ allele carriers and non-carriers with Wegener's granulomatosis.
Baslund B; Szpirt W; Eriksson S; Elzouki AN; Wiik A; Wieslander J; Petersen J
Eur J Clin Invest; 1996 Sep; 26(9):786-92. PubMed ID: 8889441
[TBL] [Abstract][Full Text] [Related]
40. Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma.
Baslund B; Petersen J; Permin H; Wiik A; Wieslander J
J Immunol Methods; 1994 Oct; 175(2):215-25. PubMed ID: 7930650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
